Jesodom 30mg/40mg Capsule SR is a combination pharmaceutical product containing Domperidone 30mg and Pantoprazole 40mg, formulated as a sustained-release capsule for the management of gastrointestinal disorders. Domperidone, a peripheral dopamine D2 receptor antagonist, facilitates gastric motility and accelerates gastric emptying, thereby alleviating symptoms such as nausea, vomiting, and bloating associated with delayed gastric emptying and gastroparesis. Pantoprazole, a proton pump inhibitor, suppresses gastric acid secretion by inhibiting the H+/K+ ATPase enzyme system at the secretory surface of gastric parietal cells, providing effective relief from acid-related disorders including gastroesophageal reflux disease (GERD), erosive esophagitis, and Zollinger-Ellison syndrome. The sustained-release formulation ensures prolonged therapeutic plasma concentrations, enhancing efficacy and patient compliance. Jesodom is indicated for patients requiring simultaneous management of acid-related symptoms and delayed gastric emptying. It should be administered as prescribed by a healthcare professional, with caution advised in patients with hepatic impairment, cardiac arrhythmias, or known hypersensitivity to either component. Common adverse effects may include headache, dry mouth, abdominal cramps, and dizziness. Drug interactions should be carefully evaluated due to Domperidone’s potential to prolong QT interval and Pantoprazole’s effect on gastric pH altering the absorption of concomitant medications.